These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4026795)

  • 21. Tau phosphorylation by diisopropyl phosphorofluoridate (DFP)-treated hen brain supernatant inhibits its binding with microtubules: role of Ca2+/Calmodulin-dependent protein kinase II in tau phosphorylation.
    Gupta RP; Abou-Donia MB
    Arch Biochem Biophys; 1999 May; 365(2):268-78. PubMed ID: 10328822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of the inhibitory interaction of organophosphorus neuropathy inducers and non-inducers in soluble esterases in the avian nervous system.
    Mangas I; Vilanova E; Estévez J
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):360-8. PubMed ID: 21600909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and properties of esterases characteristic of adult rat brain.
    Dabich D; Chakrapani B; Syner FN
    Biochem J; 1968 Dec; 110(4):713-9. PubMed ID: 5704818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrolyzing activities of phenyl valerate sensitive to organophosphorus compounds paraoxon and mipafox in human neuroblastoma SH-SY5Y cells.
    González-González M; Estévez J; Del Río E; Vilanova E; Sogorb MA
    Toxicology; 2018 Aug; 406-407():123-128. PubMed ID: 30118792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
    Chemnitius JM; Zech R
    Mol Pharmacol; 1983 May; 23(3):717-23. PubMed ID: 6865914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatographic characterization of neurotoxic esterase.
    Pope CN; Padilla SS
    Biochem Pharmacol; 1989 Jan; 38(1):181-8. PubMed ID: 2910299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation at neutral pH value of 32P-labelled proteins in a membrane preparation from ox brain. Partial characterization of component of the sodium-plus-potassium ion-activited adenosine triphosphatase.
    Alexander DR; Rodnight R
    Biochem J; 1974 Feb; 137(2):253-62. PubMed ID: 4363110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis and the mechanism for the initiation of organophosphorous compound-induced delayed neurotoxicity.
    Carrington CD
    Arch Toxicol; 1989; 63(3):165-72. PubMed ID: 2669680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of binding sites for diisopropyl phosphorofluoridate in membrane and cytosol preparations from spinal cord and brain of hens.
    Kamata R; Saito SY; Suzuki T; Takewaki T; Kofujita H; Ota M; Kobayashi H
    Neurotoxicology; 2001 Apr; 22(2):191-202. PubMed ID: 11405251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of delayed neuropathy caused by some organophosphorus esters: using the understanding to improve safety.
    Johnson MK
    J Environ Sci Health B; 1980; 15(6):823-41. PubMed ID: 7002990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH).
    Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E
    J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro effects of diisopropyl phosphorofluoridate (DFP) on the rate of hen brain tubulin polymerization.
    Gupta RP; Abou-Donia MB
    Neurochem Res; 1994 Apr; 19(4):435-44. PubMed ID: 8065500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection by some carbamates against the delayed neurotoxic effects of di-isopropyl phosphorofluoridate.
    Johnson MK; Lauwerys R
    Nature; 1969 Jun; 222(5198):1066-7. PubMed ID: 5787089
    [No Abstract]   [Full Text] [Related]  

  • 34. Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential.
    Johnson MK
    Arch Toxicol; 1977 Jun; 37(2):113-5. PubMed ID: 577680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylmethylsulfonyl fluoride alters sensitivity to organophosphorus-induced delayed neurotoxicity in developing animals.
    Pope CN; Chapman ML; Tanaka D; Padilla S
    Neurotoxicology; 1992; 13(2):355-64. PubMed ID: 1436755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active-site determinations on forms of mammalian brain and eel acetylcholinesterase.
    Gordon MA; Chan SL; Trevor AJ
    Biochem J; 1976 Jul; 157(1):69-76. PubMed ID: 962865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brainstem axolemmal protein phosphorylation in vitro in hens dosed with di-1-butyl-2,2-dichlorovinyl phosphate.
    Huggins DJ; Richardson RJ
    J Toxicol Environ Health A; 1999 Feb; 56(4):263-82. PubMed ID: 10706244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
    Wu SY; Casida JE
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of neuropathy inducers and potentiators/promoters with soluble esterases.
    Estévez J; Mangas I; Sogorb MÁ; Vilanova E
    Chem Biol Interact; 2013 Mar; 203(1):245-50. PubMed ID: 23200747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role of microtubules and associated proteases in organophosphorus ester-induced delayed neurotoxicity.
    Seifert J; Casida JE
    Biochem Pharmacol; 1982 Jun; 31(11):2065-70. PubMed ID: 6288049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.